Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2017 AND VI 35 AND IP 10
Results: 10
1
2
Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
3
Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.
- Published in:
- 2017
- By:
- Publication type:
- journal article
4
Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology.
- Published in:
- 2017
- By:
- Publication type:
- journal article
5
Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
6
Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in Code.
- Published in:
- PharmacoEconomics, 2017, v. 35, n. 10, p. 1103, doi. 10.1007/s40273-017-0534-0
- By:
- Publication type:
- Article
7
Availability and Pricing New Medicines in Ireland: Reflections and Reform.
- Published in:
- 2017
- By:
- Publication type:
- journal article
8
Performance-Based Risk-Sharing Arrangements: An Updated International Review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
9
ICER's Revised Value Assessment Framework for 2017-2019: A Critique.
- Published in:
- 2017
- By:
- Publication type:
- Letter
10
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article